Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures

The Lancet Respiratory Medicine

Volumn 8, Issue 7, 2020, Pages 687-695

  Hui, Kenrie P Y ^a   Cheung, Man Chun ^a   Perera, Ranawaka A P M ^a   Ng, Ka Chun ^a   Bui, Christine H T ^a   Ho, John C W ^a   Ng, Mandy M T ^a   Kuok, Denise I T ^a   Shih, Kendrick C ^a   Tsao, Sai Wah ^a   Poon, Leo L M ^a   Peiris, Malik ^a   Nicholls, John M ^a   Chan, Michael C W ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BRONCHUS; CACO-2 CELL LINE; CONJUNCTIVA; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H5N1); INNATE IMMUNITY; LUNG; LUNG ALVEOLUS EPITHELIUM CELL; MACROPHAGE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRAL TROPISM; VIRUS REPLICATION; VIRUS TRANSMISSION; BETACORONAVIRUS; CORONAVIRUS INFECTION; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; PANDEMIC; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY MUCOSA; VERY ELDERLY; VIROLOGY; VIRUS PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; BETACORONAVIRUS; CONJUNCTIVA; CORONAVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNITY, INNATE; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM; VIRAL TROPISM; VIRUS REPLICATION;

EID: 85084409661     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(20)30193-4     Document Type: Article

References (30)

1. WHO. MERS monthly summary, November 2019. 2019 (accessed Feb 24, 2020).
2. WHO. COVID-19 dashboard. https://covid19.who.int/, 2019. (Accessed 19 April 2020)
3. Chen, J, Pathogenicity and transmissibility of 2019-nCoV—a quick overview and comparison with other emerging viruses. Microbes Infect 22 (2020), 69–71.
4. Xu, Z, Shi, L, Wang, Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8 (2020), 420–422.
5. Tian, S, Hu, W, Niu, L, Liu, H, Xu, H, Xiao, SY, Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol, 2020 published online Feb 28. DOI:10.1016/j.jtho.2020.02.010.
6. Chan, MC, Chan, RW, Yu, WC, et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 176 (2010), 1828–1840.
7. Chu, DKW, Hui, KPY, Perera, RAPM, et al. MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc Natl Acad Sci USA 115 (2018), 3144–3149.
8. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506.
9. Hui, KP, Chan, LL, Kuok, DI, et al. Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract. Eur Respir J, 49, 2017, 1601710.
10. Chu, DKW, Pan, Y, Cheng, SMS, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 66 (2020), 549–555.
11. Nicholls, JM, Butany, J, Poon, LL, et al. Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med, 3, 2006, e27.
12. Mok, CK, Lee, HH, Lestra, M, et al. Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts. J Virol 88 (2014), 3568–3576.
13. Hui, KPY, Ching, RHH, Chan, SKH, et al. Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures. Lancet Respir Med 6 (2018), 846–854.
14. Xia, J, Tong, J, Liu, M, Shen, Y, Guo, D, Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 92 (2020), 589–594.
15. Zhang, W, Du, RH, Li, B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 9 (2020), 386–389.
16. Zou, L, Ruan, F, Huang, M, et al. SARS-CoV-2 Viral load in upper respiratory specimens of infected patients. N Engl J Med 382 (2020), 1177–1179.
17. Pan, Y, Zhang, D, Yang, P, Poon, LLM, Wang, Q, Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis 20 (2020), 411–412.
18. Munster, VJ, Feldmann, F, Williamson, BN, et al. Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2. bioRxiv, 2020 published online March 21. DOI: 10.1101/2020.03.21.001628 (preprint).
19. Rockx, B, Kuiken, T, Herfst, S, et al. Comparative pathogenesis of COVID-19, MERS and SARS in a non-human primate model. Science, 2020 published online April 17. DOI:10.1126/science.abb7314.
20. Zhou, P, Yang, XL, Wang, XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (2020), 270–273.
21. Hoffmann, M, Kleine-Weber, H, Schroeder, S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181 (2020), 271–280.
22. Bertram, S, Glowacka, I, Müller, MA, et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol 85 (2011), 13363–13372.
23. Bertram, S, Heurich, A, Lavender, H, et al. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One, 7, 2012, e35876.
24. Tong Meng, HC, Zhang, H, Kang, Z, et al. The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS. bioRxiv, 2020 published online Feb 16. DOI: 10.1101/2020.02.08.926006 (preprint).
25. Imai, Y, Kuba, K, Rao, S, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 436 (2005), 112–116.
26. Zhang, Y, Chen, C, Zhu, S, et al. Isolation of 2019-nCoV from a stool specimen of a laboratory-confirmed case of the coronavirus disease 2019 (COVID-19). http://weekly.chinacdc.cn/en/article/id/ffa97a96-db2a-4715-9dfb-ef662660e89d, 2020. (Accessed 3 April 2020)
27. Harcourt, J, Tamin, A, Lu, X, et al. Severe acute respiratory syndrome coronavirus 2 from patient with 2019 novel coronavirus disease, United States. Emerg Infect Dis, 2020 published online March 11. DOI:10.3201/eid2606.200516.
28. Chan, RW, Chan, MC, Agnihothram, S, et al. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J Virol 87 (2013), 6604–6614.
29. Cheung, CY, Poon, LL, Lau, AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 360 (2002), 1831–1837.
30. Mossel, EC, Wang, J, Jeffers, S, et al. SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology 372 (2008), 127–135.